https://aus.techrays360.com/sample-page/2024-05-07T03:41:41+00:00https://aus.techrays360.com/2024-10-27T16:09:02+00:00https://aus.techrays360.com/controlled-substance-laws/2024-10-23T15:26:03+00:00https://aus.techrays360.com/prescriber-education/2024-10-17T14:15:36+00:00https://aus.techrays360.com/controlled-substance-license-education-requirements/2024-08-07T04:44:06+00:00https://aus.techrays360.com/license-renewal-information/2024-10-17T14:23:38+00:00https://aus.techrays360.com/trainings-workshops/2024-10-17T14:29:19+00:00https://aus.techrays360.com/patient-resources/2024-10-15T17:35:32+00:00https://aus.techrays360.com/harm-risk-reduction/2024-08-08T12:47:58+00:00https://aus.techrays360.com/support-services/2024-10-23T15:20:37+00:00https://aus.techrays360.com/naloxone-support/2024-08-21T16:03:00+00:00https://aus.techrays360.com/naloxone-training/2024-08-21T16:06:07+00:00https://aus.techrays360.com/patient-handouts/2024-10-27T16:33:54+00:00https://aus.techrays360.com/treatment-and-referral-resources/2024-10-21T17:22:24+00:00https://aus.techrays360.com/prescribing-guidelines/2024-10-17T14:31:02+00:00https://aus.techrays360.com/cdc-recommendation-1/2024-10-17T14:40:33+00:00https://aus.techrays360.com/cdc-recommendation-2/2024-10-27T16:38:27+00:00https://aus.techrays360.com/cdc-recommendation-3/2024-10-17T14:50:01+00:00https://aus.techrays360.com/cdc-recommendation-4/2024-10-17T14:51:20+00:00https://aus.techrays360.com/cdc-recommendation-5/2024-10-17T14:51:58+00:00https://aus.techrays360.com/cdc-recommendation-6/2024-10-17T14:52:54+00:00https://aus.techrays360.com/cdc-recommendation-7/2024-10-17T14:54:18+00:00https://aus.techrays360.com/cdc-recommendation-8/2024-10-17T14:55:27+00:00https://aus.techrays360.com/cdc-recommendation-9/2024-10-17T14:56:47+00:00https://aus.techrays360.com/cdc-recommendation-10/2024-10-17T14:41:15+00:00https://aus.techrays360.com/cdc-recommendation-11/2024-10-17T14:41:54+00:00https://aus.techrays360.com/cdc-recommendation-12/2024-10-17T14:46:42+00:00https://aus.techrays360.com/prescriber-resources/2024-10-15T17:53:26+00:00https://aus.techrays360.com/peer-to-peer-clinical-support/2024-10-15T18:00:52+00:00https://aus.techrays360.com/tools-for-assessing-substance-use-risk/2024-10-17T13:41:06+00:00https://aus.techrays360.com/tools-for-assessing-pain/2024-10-23T15:23:52+00:00https://aus.techrays360.com/tools-for-screening-mental-health-conditions-and-suicide-risk/2024-10-17T13:47:17+00:00https://aus.techrays360.com/contract-for-controlled-substances-and-suicide-risk/2024-10-17T13:48:35+00:00https://aus.techrays360.com/medication-conversion-tools/2024-10-17T13:50:06+00:00https://aus.techrays360.com/stigma-reducing-language/2024-10-17T13:51:29+00:00https://aus.techrays360.com/motivational-interviewing/2024-10-17T13:52:16+00:00https://aus.techrays360.com/difficult-conversations/2024-10-17T13:56:27+00:00https://aus.techrays360.com/acute-or-opioid-naive/2024-10-17T13:59:05+00:00https://aus.techrays360.com/chronic-long-term/2024-10-17T14:03:43+00:00https://aus.techrays360.com/pediatric-pain/2024-10-17T14:05:56+00:00https://aus.techrays360.com/polysubstance-prescribing/2024-10-27T16:28:55+00:00https://aus.techrays360.com/naloxone-prescribing/2024-10-27T16:35:48+00:00https://aus.techrays360.com/data/2024-10-21T17:30:54+00:00https://aus.techrays360.com/utah-based-programs/2024-10-21T17:32:15+00:00https://aus.techrays360.com/gabapentin-update/2024-10-17T15:34:25+00:00https://aus.techrays360.com/e-prescribing/2024-10-17T15:35:13+00:00https://aus.techrays360.com/interstate-prescribing/2024-10-27T16:41:53+00:00https://aus.techrays360.com/telehealth-prescribing/2024-10-17T15:40:22+00:00https://aus.techrays360.com/utah-research-articles/2024-10-27T16:43:18+00:00https://aus.techrays360.com/whats-going-on-in-utah/2024-10-17T15:44:59+00:00https://aus.techrays360.com/updates/2024-10-17T15:33:13+00:00